Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement
AUDUSD0.6583
0.0001 (0.02%)0.02%
SPI 2007,550.00
27.00 (0.36%)0.36%
S&P/ASX 2007,555.40
36.20 (0.48%)0.48%
All Ords7,785.20
37.10 (0.48%)0.48%
NZX 504,564.43
-5.61 (-0.12%)-0.12%
Hang Seng15,952.23
-259.73 (-1.60%)-1.60%
Nikkei35,751.07
-485.40 (-1.34%)-1.34%
View all

Latest

Tesla investors see ‘no floor’ after losing $300b

“If Tesla is lowering its forecast and is not bullish on the near term, why should investors be bullish,” 50 Park Investments’s Adam Sarhan asks.

  • 25 mins ago
  • Esha Dey
The New York Stock Exchange.

US stocks fluctuate, March rate bets pared, bitcoin rallies

Shares fluctuated between positive and negative as traders, economists see Fed in no rush to cut in March. Tesla steadied as Intel dropped.

  • 1 hr ago
  • Timothy Moore

S&P 500 resets closing record high even as Tesla crashes

The US benchmark extended its advance for a fifth consecutive session. Tesla tumbled 12pc. Oil topped $US82 a barrel.

  • Updated
  • Timothy Moore

‘Fundamentally magnificent’ US megacaps: Leuthold Group

For Scott Opsal, the key, and simple, reason why US megacaps have outperformed other members of the S&P 500 is because of their “superb business results”.

  • Timothy Moore

Tax relief may push out first RBA rate cut: economists

While changes to the stage three tax cuts won’t derail the Reserve Bank interest rate outlook, some economists say it could delay the first rate cut.

  • Cecile Lefort and Joanne Tran

Newmark shareholders agitate against BWP property merger

Newmark investor Winston Sammut says he will call a unitholder meeting in an attempt to have BWP’s bid voted down.

  • Tom Richardson

Opinion & Analysis

Wall Street can’t stop setting records. But a big test is coming

Five record highs in a row underscores the exuberance that’s taken over markets. But four key events in the next week could test investor resolve. 

Chanticleer

Columnist

Chanticleer

Why Australia’s biggest and oldest LIC defied the Ozempic sell-off

Australian Foundation Investment Company boss Mark Freeman says buying CSL and Resmed amid last year’s Ozempic rout was part of a tried-and-true strategy. 

Chanticleer

Columnist

Chanticleer

Albanese’s tax cut dance shows why investors must watch politics

The government feeling pressed to deliver cost-of-living relief outside an election year is a reminder 2024’s big slate of global elections may bring fiscal stimulus.

Chanticleer

Columnist

Chanticleer

Three ways the Future Fund is dodging expensive equities

Raphael Arndt says stocks look expensive as investors bet on rate cuts and strong growth. Here are three places the fund is hunting for returns instead. 

Chanticleer

Columnist

Chanticleer

Companies in the News

BHP Group

bhp$47.540
 1.45%

ANZ Bank

anz$26.670
 0.30%

Commonwealth Bank

cba$114.860
 0.14%

Liontown Resources

ltr$0.920
 -2.13%

Pilbara Minerals

pls$3.530
 2.02%

Updated: Jan 25, 2024 – 4.10pm. Data is 20 mins delayed.

Search companies

View stories and data from an ASX listed company

Advertisement

Meet the Fundie

Fairlight’s newest recruit, Abbey Cook.

Fairlight’s newest recruit, Abbey Cook, is betting big on beauty

The fund manager explains why she is so bullish on one US retailer and what she learnt from co-founding homegrown hedge fund VGI Partners with Rob Luciano.

  • Joanne Tran
QVG co-founder Chris Prunty (left) and portfolio manager Josh Clark.

This hedge fund backs ‘spicy shorts’ other firms won’t touch

Chris Prunty and Josh Clark reveal the lessons learnt since launching QVG’s long-short fund five years ago, and why they recently reduced their Core Lithium short.

  • Joshua Peach
WaveStone’s Raaz Bhuyan is confident Rio Tinto is on track to mend its relationship with traditional owners.

This fundie blasted Rio Tinto – then doubled down on his investment

WaveStone Capital’s Raaz Bhuyan talks about his latest trip to the Pilbara and how he was horrified by the miner’s initial response to the Juukan Gorge scandal.

  • Joanne Tran

Yesterday

Investors are riding this new year rally with all they’ve got.

Wall Street can’t stop setting records. But a big test is coming

Five record highs in a row underscores the exuberance that’s taken over markets. But four key events in the next week could test investor resolve. 

  • James Thomson

This Month

Maple Brown-Abbott portfolio manager Phillip Hudak.

Small caps are at an ‘inflection point’: Maple Brown-Abbott

Fund manager Phillip Hudak is feeling good about the upcoming reporting season for small companies and shares why he’s expecting gold miners to make a comeback.

  • Joanne Tran
The ASX is poised to open higher.

ASX charts fifth session of gains, led by miners; Domino’s sinks 30pc

Australian shares end higher as iron ore rallies anew. Domino’s plummets after revoking guidance. ResMed rallies on stable dividend. Incitec Pivot pays out $500 million to shareholders.

  • Timothy Moore, Joshua Peach, Sarah Jones, Joanne Tran and Cecile Lefort
The New York Stock Exchange.

ASX to rise amid global tech sector rally

Australian shares are set to open higher. Tech shares surged in Europe. Microsoft breaches $US3 trillion. S&P 500 briefly tops 4900 point mark.

  • Updated
  • Timothy Moore

Investors turn to copper, gold and uranium amid battery metals rout

The collapse in battery metals has many investors fleeing nickel and lithium plays for safer waters. Here are the commodities fund managers have turned to in 2024.

  • Joshua Peach
Advertisement
The ASX is poised to open higher.

ASX closes firm, worst day for Nanosonics

Shares edge up; US stocks break record high; Nanosonics misses guidance; BWP and Newmark in $3.5b merger; Woodside record output. Follow updates here.

  • Updated
  • Timothy Moore, Cecile Lefort, Joshua Peach, Joanne Tran and Vesna Poljak
Mark Freeman says AFIC’s will always find opportunities to add to its high-quality portfolio in any given year.

Why Australia’s biggest and oldest LIC defied the Ozempic sell-off

Australian Foundation Investment Company boss Mark Freeman says buying CSL and Resmed amid last year’s Ozempic rout was part of a tried-and-true strategy. 

  • James Thomson
The Pilgangoora Lithium Project in Western Australia: Prices for the batteries commodity have slumped over the past year.

Fundies spy buying opportunities in lithium rout

Fund managers said some stocks are opportunities for those prepared to take a three- to five-year view, but other explorers face a cash flow crunch.

  • Tom Richardson
The New York Stock Exchange.

ASX to rise, S&P 500 resets closing high

Australian futures have turned positive as US stocks shook off mixed earnings. Bitcoin extends slide.

  • Updated
  • Timothy Moore
The airline’s full-year forecast suggests a sharp turnaround after this quarter.

US reporting season: hits and misses

United Airlines, 3M, GE, Verizon, J&J, P&G, Halliburton, DR Horton and Invesco were among the latest corporates to report results.

“Xi Jinping’s people are almost certainly telling him that the rout in the equity market is a stability risk,” said George Magnus, a research associate at Oxford University’s China Centre.

China’s bold stock-market rescue plan leaves investors sceptical

It’s hard to blame investors for their cynicism. China has a history of marshalling policy resources to stanch market bleeding, but few succeeded.

  • Bloomberg
The pressure on the Labor government  to deliver cost-of-living relief is building.

Albanese’s tax cut dance shows why investors must watch politics

The government feeling pressed to deliver cost-of-living relief outside an election year is a reminder 2024’s big slate of global elections may bring fiscal stimulus.

  • Updated
  • James Thomson
LHC Capital’s Stephen Aboud and Marcus Hughes.

Hedge fund LHC buys ResMed, bets against sceptics

The sleep apnoea devices maker and Lottery Corporation are the new additions to Sydney-based LHC Capital’s portfolio.

  • Joanne Tran
Fed governor Christopher Waller has tried to temper aggressive rate cut expectations.

Markets still too bullish on interest rate cuts

Bond investors are cautioning that expectations of imminent rate cuts are a touch too aggressive, even after traders have dialled back their bets.

  • Cecile Lefort
Future Fund chief executive Raphael Arndt hasn’t waved goodbye to an inflationary environment quite yet.

Three ways the Future Fund is dodging expensive equities

Raphael Arndt says stocks look expensive as investors bet on rate cuts and strong growth. Here are three places the fund is hunting for returns instead. 

  • James Thomson
Advertisement
The ASX 200 is poised to open lower.

Healthcare stocks buoy ASX; IDP slumps; BHP up

Shares advance at the closing bell; IDP plunges after Canada limits visas; Karoon cuts output guidance; Bank of Japan holds pat on rates; iron ore higher. Follow for more updates.

  • Updated
  • Timothy Moore, Joanne Tran, Cecile Lefort, Joshua Peach and Sarah Jones
The New York Stock Exchange.

ASX futures slip, S&P 500 extends ‘melt-up’

Australian shares are set to edge lower in contrast to gains in Europe and on Wall Street. Oil tops $US80 mark. Bitcoin briefly trades below $US40,000.

  • Timothy Moore
More than two thirds of the MLIV Pulse survey respondents said big gains for global stocks at the end of last year now look like a bad omen.

Wall Street’s ‘foolish’ trade is betting on early rate cuts

More than two-thirds of respondents in a market survey said the strong rally in global equity markets at the end of last year now looked like a bad omen.

  • Denitsa Tsekova
The ASX is poised to open higher, after the benchmark US equity index surged to a record high.

ASX rises as Zip soars 16pc on profit path

Shares gain; Google dumps $125m Appen contract; Lynas halves output; South32 flags headwinds; Chalice slashes costs; Liontown reviews lithium plans.

  • Updated
  • Timothy Moore, Cecile Lefort, Sarah Jones, Joshua Peach and Joanne Tran

Cost relief needs to target poor or risk more inflation

Economists warn the federal government’s new cost-of-living package should be aimed only at the most vulnerable to keep the RBA on side.

  • Joanne Tran and Sarah Jones